COST-EFFECTIVENESS OF SYSTEMIC TREATMENT INTENSIFICATION IN MEN WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER

被引：0
|
作者：
Sathianathen, Niranjan
Lawrentschuk, Nathan
Azad, Arun
Konety, Badrinath
Murphy, Declan
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD16-08
引用
收藏
页码：E492 / E492
页数：1
相关论文
共 50 条
  • [31] TITAN study: evaluation of apalutamide in patients with metastatic hormone-sensitive prostate cancer - Treatment of metastatic hormone-sensitive prostate cancer (mHSPC)
    Merseburger, Axel S.
    Suttmann, Henrik
    AKTUELLE UROLOGIE, 2021, 52 (02) : 155 - 160
  • [32] Cost-effectiveness of upfront therapeutic options in low-volume de novo metastatic hormone-sensitive prostate cancer
    Parikh, Neil Rohit
    Chang, Eric M.
    Nickols, Nicholas George
    Rettig, Matthew
    Raldow, Ann C.
    Steinberg, Michael L.
    Koontz, Bridget F.
    Vapiwala, Neha
    Deville, Curtiland
    Feng, Felix Y.
    Spratt, Daniel Eidelberg
    Reiter, Robert Evan
    Phillips, Ryan
    Tran, Phuoc T.
    Kishan, Amar Upadhyaya
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [33] Systemic treatment options for metastatic hormone-sensitive prostate cancer: making sense of the data
    Baston, Catalin
    Preda, Adrian
    Guler-Margaritis, Silviu S.
    Sinescu, Ioanel
    Gingu, Constantin
    CURRENT OPINION IN UROLOGY, 2020, 30 (04) : 576 - 583
  • [34] The Changing Landscape of Systemic Therapy in the Treatment of Synchronous Metastatic Hormone-sensitive Prostate Cancer
    Lambert, Edward
    Lumen, Nicolaas
    Fonteyne, Valerie
    De Maeseneer, Daan
    Verbeke, Sofie
    Villeirs, Geert
    De Man, Kathia
    Van Praet, Charles
    CLINICAL GENITOURINARY CANCER, 2023, 21 (03) : e1 - e8
  • [35] COST-EFFECTIVENESS OF ADDING DAROLUTAMIDE TO DOCETAXEL AND ANDROGEN DEPRIVATION THERAPY IN THE TREATMENT OF METASTATIC HORMONE-SENSITIVE PROSTRATE CANCER
    Nwogu, I. B.
    Nedzesky, J.
    Carlson, J. J.
    VALUE IN HEALTH, 2023, 26 (06) : S106 - S106
  • [36] Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer
    Bernard, Brandon
    Muralidhar, Vinayak
    Chen, Yu-Hui
    Sridhar, Srikala S.
    Mitchell, Edith P.
    Pettaway, Curtis A.
    Carducci, Michael A.
    Nguyen, Paul L.
    Sweeney, Christopher J.
    CANCER, 2017, 123 (09) : 1536 - 1544
  • [37] Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
    Spencer, Katie L.
    Tree, Alison C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (04): : 927 - 929
  • [38] Metastatic hormone-sensitive prostate cancer: local treatment strategies
    Montorsi, Francesco
    Martini, Alberto
    Gandaglia, Giorgio
    Fossati, Nicola
    Stabile, Armando
    Deho, Federico
    Salonia, Andrea
    Briganti, Alberto
    WORLD JOURNAL OF UROLOGY, 2022, 40 (03) : 881 - 882
  • [39] Metastatic hormone-sensitive prostate cancer: local treatment strategies
    Francesco Montorsi
    Alberto Martini
    Giorgio Gandaglia
    Nicola Fossati
    Armando Stabile
    Federico Dehò
    Andrea Salonia
    Alberto Briganti
    World Journal of Urology, 2022, 40 : 881 - 882
  • [40] Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
    Cattrini, Carlo
    Castro, Elena
    Lozano, Rebeca
    Zanardi, Elisa
    Rubagotti, Alessandra
    Boccardo, Francesco
    Olmos, David
    CANCERS, 2019, 11 (09)
12345